Centre hospitalier de l'Université de Montreal

Montreal, Quebec H2X 0C2

0 studies enrolling now · 3 studies all time

What they study most

Arteriovenous Fistula, Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Multiple Ground Glass Opacities (GGOs), Newly Diagnosed, Partial Response, Primary Peritoneal

Studies at this site

• Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae — Running, not enrolling
• A Registry for Patients With Multifocal Ground Glass Opacities (GGOs) — Running, not enrolling
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling